CYTOSORBENTS CORPORATION (CTSO) Gross profit 2016–2025
CYTOSORBENTS CORPORATION (CTSO) annual gross profit history from SEC filings — each fiscal year as reported.
$26.5MFY2025 · since FY2016: $5.6M → $26.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $26.5M | +6.4% |
| FY2024 | $24.9M | +13.4% |
| FY2023 | $22.0M | +5.9% |
| FY2022 | $20.7M | -35.4% |
| FY2021 | $32.1M | +7.2% |
| FY2020 | $30.0M | +70.3% |
| FY2019 | $17.6M | +17.1% |
| FY2018 | $15.0M | +55.9% |
| FY2017 | $9.6M | +72.8% |
| FY2016 | $5.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CTSO financial trends
CTSO RevenueCTSO Net incomeCTSO Net marginCTSO Gross marginCTSO Operating incomeCTSO Operating marginCTSO Operating cash flowCTSO Free cash flowCTSO Capital expendituresCTSO Return on equityCTSO Stock buybacksCTSO Dividends paidCTSO Total assetsCTSO Total liabilitiesCTSO Shareholders’ equityCTSO overview →